28.11.2019 • NewsDede Willams

US to Press Criminal Charges against Opioid Makers

US may Press Criminal Charges against Opioid Makers
US may Press Criminal Charges against Opioid Makers

Stiff fines have been issued, and at least one company has declared bankruptcy as the US continues to pursue its case against opioid manufacturers, blaming them for the “epidemic” that has reportedly claimed 400,000 lives across the country since 1999.

Now the newspaper Wall Street Journal, (WSJ), quoting sources, reports that federal prosecutors, employing laws normally used to go after drug dealers, have opened a criminal investigation into whether pharmaceutical companies intentionally allowed opioid painkillers to flood communities.

If the investigation does result in criminal charges, it could become the largest prosecution ever of drug companies alleged to have contributed to the opioid epidemic, WSJ notes, thus escalating the legal troubles of businesses that already face complex, multibillion-dollar civil litigation in US courts.

Prosecutors are said to be examining whether the companies violated the US Controlled Substances Act. In this connection, at least six companies, including drugmakers Teva Pharmaceuticals, Mallinckrodt, Johnson & Johnson and Amneal Pharmaceuticals, along with distributors AmerisourceBergen Corp and McKesson have said in regulatory filings that they have received subpoenas from the U.S. attorney’s office in the Eastern District of New York.

According to previous press reports, the targeted companies have denied responsibility for the opioid crisis. WSJ’s sources said additional companies will receive subpoenas in the coming months.

Under the Controlled Substances Act, companies are required to monitor commonly abused drugs, including by reporting suspicious orders, maintaining compliance programs and disclosing suspicious pharmacy customers to the government.

Almost every US state and more than 2,500 city and county governments have filed lawsuits against players across the opioid supply chain. The state of Ohio has settled with four companies, and hundreds of other lawsuits bundled in a Cleveland, Ohio, federal court are still pending settlement.

CHEManager Spotlight

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics
Creating Interfaces

Standardization and Harmonization of Digital Chemical and Pharmaceutical Logistics

CHEManager Spotlight is an exclusive event tailored for practitioners and decision-makers in the chemical industry. This part of our event series delves into the latest trends and innovations in logistics to streamline your operations and drive efficiency.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.